Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GRT6005 in Pain Due to Diabetic Polyneuropathy
NCT01347671Phase 2Completed
- Sponsor
- Tris Pharma
- Start
- May 2011
- Primary completion
- Jan 2012
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of cebranopadol in diabetic peripheral neuropathy (DPN), sponsored by Tris Pharma. Started May 2011; status: completed.
02
Drugs
cebranopadol
03
Conditions
diabetic peripheral neuropathy (DPN)
Beyond the preview
Go deeper on NCT01347671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01347671.